See this article by AlignRx CEO Kevin Kobielski as it originally ran in Healthcare Business Today. Carve-outs can be a thorn in the side of health plans. But with a little creative thinking in key areas, insurers can solve the problems that cause employer groups to rely on carve-outs. For employers, the appeal of carve-outs […]
Brian Shonat, Goodroot’s area vice president of business development, recently joined Spencer Smith on the Self-Funded with Spencer podcast to talk AlignRx, PBM contracts, specialty drugs and more. Below are some of the highlights of what Brian had to say during the hour-long chat. Listen to the full episode on the Self-Funded with Spencer podcast.
The RxDC Reporting Deadline is Approaching—Are you Prepared? At AlignRx, we provide our valued TPA partners and their employer groups with year-round pharmacy consulting and expertise. The RxDC mandate is no exception. We covered: PBM timelines—and how they impact yours Understanding PBM charges for data submission communicating them with your clients Rebates, rebates, rebates! Ensuring
The RxDC Reporting Deadline Is Approaching—Are You Prepared? The Consolidated Appropriations Act has a new Rx mandate for your employer groups and the deadline is approaching—are you prepared? The new mandate requires employer-based health plans to submit information about prescription drug and healthcare spending to the Departments of Health & Human Services, Labor, and the
Brokers and employer groups alike know that 5% to 10% percent of insured workers and their dependents drive 50% to 60% of the cost of pharmacy claims. A few members with prescriptions for a specialty drug with a five-figure price tag can easily represent the majority of an entire group’s pharmacy spend. These drugs are